Skip to Content
Home > About Us > Research and Grants Administration > Detail
<< Back to Results
This randomized phase III trial is studying giving patients FOLFOX which includes oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) to compare how well they work when given together with or without celecoxib in treating patients with stage III colon cancer previously treated with surgery.
For more information on this trial, visit the National Cancer Institute.
View Additional Section Content
For more information about our research program and IRB, please contact: